BackTable Vascular & Interventional Ep. 548 Winding Down Neuwave: Impact on Interventional Radiology with Dr. Joshua Kuban
6 snips
May 30, 2025 Dr. Joshua Kuban, an interventional radiologist at MD Anderson Cancer Center, discusses the significant impacts of NeuWave's discontinuation of its microwave tumor ablation technology. He reflects on how NeuWave reshaped interventional oncology and held over 50% of the microwave market. The conversation explores strategies for adapting to alternative technologies and highlights the evolving landscape of ablation confirmation and emerging robotic technologies. Kuban emphasizes the importance of collaboration and innovation for the future of interventional radiology.
AI Snips
Chapters
Transcript
Episode notes
NeuWave's Impact on Patients
- Dr. Kuban shares how NeuWave's microwave ablation system greatly improved patient care with safe, effective procedures.
- He felt shocked and saddened by the news of its discontinuation due to its proven clinical value.
IR Community's Unique Reaction
- The IR community is notably upset about NeuWave winding down because they rely heavily on its system.
- This reaction differs from surgeons, who often see such devices as interchangeable commodities.
Begin Early Device Transition
- Start transition to alternative microwave ablation devices now by using them in easier cases to gain experience.
- Avoid waiting until the last minute to switch, as familiarity with the devices is critical for patient safety.